Latest News
Research, Community Engagement & Health Equity, Center News & Funding
Stand Up To Cancer and Southeastern cancer centers fight racial inequities in lung cancer
Mar 15, 2022
VCU Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and University of North Carolina Lineberger Comprehensive Cancer Center secured a four-year, $3 million grant from Stand Up To Cancer® (SU2C) that will establish the SU2C Lung Cancer Health Equity Research Team and build on the long-standing community outreach and engagement efforts of these institutions to develop culturally-sensitive, community-informed interventions aimed at reducing lung cancer disparities.
This grant is made possible by the support of Bristol Myers Squibb and is a part of SU2C’s Health Equity Initiative, which was announced in 2020 and focuses on increasing diversity in cancer clinical trials, initiating advocacy group collaborations and awareness campaigns, and funding research aimed at improving cancer outcomes and screening rates in medically underserved communities.
Black Americans are disproportionately impacted by social determinants of health, which can increase their risk for smoking and limit their access to lung cancer screening and care.
This grant will establish the Southeastern Consortium for Lung Cancer Health Equity to address these deeply ingrained disparities that contribute to a higher incidence of lung cancer in Black communities across Virginia and the Carolinas, which lie in the heart of America’s tobacco-producing region and are among the states with the highest concentration of Black residents.
“For this project, we will work with our partners to set up a sustainable research and outreach infrastructure in Virginia, North Carolina and South Carolina, to ensure that our communities continue to reap the benefits of these efforts for years to come, not just for the duration of this particular grant,” said team leader Robert Winn, M.D., director and Lipman Chair in Oncology at VCU Massey, senior associate dean for cancer innovation and a professor of pulmonary disease and critical care medicine at the VCU School of Medicine.
As part of this project, each of the three centers will partner with their local federally-qualified health centers (FQHCs) – community clinics that receive special funding from the federal government to provide primary care in underserved areas. Hollings will partner with the Fetter Health Care Network, Massey will partner with the Capital Area Health Network, Vernon Harris FQHC in Richmond, and Lineberger will partner with Kintegra FQHC system.
Community navigators within the FQHCs and nurse and financial navigators within the cancer centers will guide patients through lung cancer screening by providing education and support. These teams of navigators aim to remove the variety of barriers that underserved patients face.
“Lung cancer screening has the potential to reduce lung cancer mortality and close the disparities gap, yet initial reports indicate low uptake of screening,” Louise Henderson, Ph.D., the team’s principal investigator and program leader of cancer epidemiology at UNC Lineberger. “Through this team science grant, we will incorporate the cells-to-society approach in our work with community partners and patient advocates to test multilevel interventions aimed at increasing lung cancer screening.”
The second part of the project will involve pooling patient sample repositories across the three cancer centers to create the largest collection of curated clinical data and biospecimens from Black Americans at risk for or diagnosed with lung cancer.
Existing biobanks are sorely lacking on racial diversity, which in turn hampers clinicians’ ability to take their patients’ race into account when determining the best prevention or treatment plan.
"We have designed a project that is truly translational by combining basic science and community outreach approaches,” said Marvella Ford, Ph.D., team co-leader and associate director of cancer disparities at MUSC Hollings Cancer Center. “I think it is important for states that are facing similar disparities to unite and come together to develop this consortium that gives us more leverage than we would have individually. We’re all facing the same battle, but we can fight it much better together.”
Written by: Erin Hare
Related News
Research, Community Engagement & Health Equity, Center News & Funding, Prevention & Control, Massey 50
Fifty years of Massey: A conversation between Robert A. Winn, M.D., and Becky MasseyNov 22, 2024
Research, Center News & Funding
Through a $13M NCI grant, a team of Massey scientists could change the way liver cancer is treatedOct 18, 2024
Get access to new, innovative care
Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.
Find a provider
Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.